1-hydroxymethylmidazolam glucuronide and Neoplasms

1-hydroxymethylmidazolam glucuronide has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goh, BC; Hee, KH; Lee, LS; Sapari, NS; Seng, KY; Soon, GH; Soong, R	1

Trials

1 trial(s) available for 1-hydroxymethylmidazolam glucuronide and Neoplasms

Article	Year
CYP3A53 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients. Journal of clinical pharmacology, 2014, Volume: 54, Issue:2* Topics: Adult; Aged; Anti-Anxiety Agents; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Neoplasms; Polymorphism, Genetic	2014

Article

Year

CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients.

Journal of clinical pharmacology, 2014, Volume: 54, Issue:2

Topics: Adult; Aged; Anti-Anxiety Agents; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Neoplasms; Polymorphism, Genetic

2014